Roivant prices rare disease drug Lisraya at $35,000/month
Roivant set the price for its rare disease drug Lisraya at $35,000 a month.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.